Linda Palczuk - Net Worth and Insider Trading
Linda Palczuk Net Worth
The estimated net worth of Linda Palczuk is at least $710,018 dollars as of 2024-12-27. Linda Palczuk is the Director of Avadel Pharmaceuticals PLC and owns about 66,400 shares of Avadel Pharmaceuticals PLC (AVDL) stock worth over $704,504. Linda Palczuk is also the COO of Verrica Pharmaceuticals Inc and owns about 8,500 shares of Verrica Pharmaceuticals Inc (VRCA) stock worth over $5,514. Details can be seen in Linda Palczuk's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Linda Palczuk has not made any transactions after 2024-12-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Linda Palczuk
Linda Palczuk Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Linda Palczuk owns 3 companies in total, including Avadel Pharmaceuticals PLC (AVDL) , Verrica Pharmaceuticals Inc (VRCA) , and Osiris Therapeutics Inc (OSIR) .
Click here to see the complete history of Linda Palczuk’s form 4 insider trades.
Insider Ownership Summary of Linda Palczuk
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AVDL | Avadel Pharmaceuticals PLC | 2024-12-06 | director |
| VRCA | Verrica Pharmaceuticals Inc | 2019-01-16 | Chief Operating Officer |
| OSIR | Osiris Therapeutics Inc | 2017-07-10 | President & CEO |
Linda Palczuk Latest Holdings Summary
Linda Palczuk currently owns a total of 2 stocks. Among these stocks, Linda Palczuk owns 66,400 shares of Avadel Pharmaceuticals PLC (AVDL) as of December 6, 2024, with a value of $704,504 and a weighting of 99.22%. Linda Palczuk also owns 8,500 shares of Verrica Pharmaceuticals Inc (VRCA) as of January 16, 2019, with a value of $5,514 and a weighting of 0.78%.
Latest Holdings of Linda Palczuk
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AVDL | Avadel Pharmaceuticals PLC | 2024-12-06 | 66,400 | 10.61 | 704,504 |
| VRCA | Verrica Pharmaceuticals Inc | 2019-01-16 | 8,500 | 0.65 | 5,514 |
Holding Weightings of Linda Palczuk
Linda Palczuk Form 4 Trading Tracker
According to the SEC Form 4 filings, Linda Palczuk has made a total of 5 transactions in Avadel Pharmaceuticals PLC (AVDL) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Avadel Pharmaceuticals PLC is the acquisition of 3,000 shares on December 6, 2024, which cost Linda Palczuk around $30,570.
According to the SEC Form 4 filings, Linda Palczuk has made a total of 0 transactions in Verrica Pharmaceuticals Inc (VRCA) over the past 5 years. The most-recent trade in Verrica Pharmaceuticals Inc is the acquisition of 3,000 shares on January 16, 2019, which cost Linda Palczuk around $31,590.
Insider Trading History of Linda Palczuk
- 1
Linda Palczuk Trading Performance
GuruFocus tracks the stock performance after each of Linda Palczuk's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Linda Palczuk is 23.54%. GuruFocus also compares Linda Palczuk's trading performance to market benchmark return within the same time period. The performance of stocks bought by Linda Palczuk within 3 months outperforms 3 times out of 8 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Linda Palczuk's insider trading performs compared to the benchmark.
Performance of Linda Palczuk
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.75 | | | | | |
| Relative Return to S&P 500(%) | -3.31 | | | | | |
Linda Palczuk Ownership Network
Linda Palczuk Owned Company Details
What does Avadel Pharmaceuticals PLC do?
Who are the key executives at Avadel Pharmaceuticals PLC?
Linda Palczuk is the director of Avadel Pharmaceuticals PLC. Other key executives at Avadel Pharmaceuticals PLC include Chief Financial Officer Thomas S Mchugh , director & Chief Executive Officer Greg J Divis , and Chief Commercial Officer Richard J Kim .
Avadel Pharmaceuticals PLC (AVDL) Insider Trades Summary
Over the past 18 months, Linda Palczuk made 1 insider transaction in Avadel Pharmaceuticals PLC (AVDL) with a net purchase of 3,000. Other recent insider transactions involving Avadel Pharmaceuticals PLC (AVDL) include a net purchase of 11,300 shares made by Thomas S Mchugh , a net sale of 103,975 shares made by Mark Anthony Mccamish , and a net purchase of 34,279 shares made by Geoffrey Michael Glass .
In summary, during the past 3 months, insiders sold 0 shares of Avadel Pharmaceuticals PLC (AVDL) in total and bought 40,579 shares, with a net purchase of 40,579 shares. During the past 18 months, 103,975 shares of Avadel Pharmaceuticals PLC (AVDL) were sold and 68,579 shares were bought by its insiders, resulting in a net sale of 35,396 shares.
Avadel Pharmaceuticals PLC (AVDL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avadel Pharmaceuticals PLC Insider Transactions
Linda Palczuk Mailing Address
Above is the net worth, insider trading, and ownership report for Linda Palczuk. You might contact Linda Palczuk via mailing address: 7015 Albert Einstein Drive, Columbia Md 21046.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
